Floatz logo

Autologous Ccr4 Car T Cells

Enteropathy Associated T-cell Lymphoma

National Cancer Institute (NCI)Cell therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

20 Active assets in the Enteropathy Associated T-cell Lymphoma cohort.

Asset / SponsorPhaseRating
Inno-206
Eric Jacobsen, MD
Phase 4BBB
ETOPOSIDE
Eric Jacobsen, MD
Phase 4BBB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 4BBB
Ifosfamide
Shandong Provincial Hospital
Phase 4BB
PREDNISONE TABLETS
Eric Jacobsen, MD
Phase 4BB

View all 36 →

Same molecule, other indications

Autologous Ccr4 Car T Cells is also rated in:

neoplasm of mature T-cells or NK-cellsDormant
CC
Indicative ·
43 / 100
View asset →
hepatosplenic T-cell lymphomaDormant
CC
Indicative ·
43 / 100
View asset →
monomorphic epitheliotropic intestinal T-cell lymphomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →